Medical Procedure News

RSS

Robot-assisted surgery more common and successful in treating prostate cancer

Robot-assisted surgery is now both more common and far more successful than radical "open" surgery to treat prostate cancer in the United States, according to a new Henry Ford Hospital study published in the current issue of the medical journal European Urology.

24 Apr 2012

Study: hUC-MSCs reduce inflammation that causes colitis

When laboratory mice were modeled with colitis and treated with human umbilical cord-derived mesenchymal cells, the cells homed in on the inflamed colon and effectively ameliorated colitis, reported a study published in a recent issue of Cell Transplantation.

24 Apr 2012

Study shows how acupuncture therapy holds promise for skeletal muscle atrophy

A team of Japanese researchers will reveal study results Monday at the Experimental Biology 2012 meeting that show how acupuncture therapy mitigates skeletal muscle loss and holds promise for those seeking improved mobility through muscle rejuvenation.

24 Apr 2012

Novel technological treatment for Leber Hereditary Optic Neuropathy

A research team, led by John Guy, M.D., professor of ophthalmology at Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine, has pioneered a novel technological treatment for Leber Hereditary Optic Neuropathy (LHON), an inherited genetic defect that causes rapid, permanent, and bilateral loss of vision in people of all ages, but primarily males ages 20-40.

24 Apr 2012

Study shows underutilization of epilepsy surgery

Ten years ago, a landmark clinical trial in Canada demonstrated the unequivocal effectiveness of brain surgeries for treating uncontrolled epilepsy, but since then the procedure has not been widely adopted-in fact, it is dramatically underutilized according to a new study from the University of California, San Francisco (UCSF).

24 Apr 2012

Beta cells from genetically modified pigs can effectively restore pancreas function

Transplantation of a whole pancreas or isolated insulin-producing beta cells are the only therapy to cure type 1 diabetes. However, the shortage of organ donors limits this approach to only few patients. LMU researchers have now shown that beta cells from genetically modified pigs can effectively restore pancreas function and can protect porcine beta cells from immune rejection in animal models.

23 Apr 2012

DSG's eCaseLink EDC chosen for Ariosa's Non-Invasive Chromosomal Examination of Trisomy study

Ariosa Diagnostics, a molecular diagnostics company focused on prenatal testing, has chosen to use DSG's eCaseLink EDC (electronic data capture) system for the NEXT (Non-Invasive Chromosomal Examination of Trisomy) study.

23 Apr 2012

Laparoscopy associated with lesser risk of small-bowel obstructions

Open surgery appears to be associated with an increased risk of small-bowel obstructions compared to laparoscopic procedures. This is shown by a new study at the Sahlgrenska Academy, at the University of Gothenburg, Sweden.

23 Apr 2012

New titanium vertebral body replacement device from ulrich medical

ulrich medical USA, Inc., today announced the release of the Omni VBR Implant System, a new titanium vertebral body replacement device that is intended for use in the thoracic and lumbar spine (T1-L5) to replace a collapsed, damaged or unstable vertebral body due to tumor or trauma.

23 Apr 2012

Enrollment complete in REPRISE I clinical trial for Lotus Aortic Valve System

Boston Scientific Corporation announces that it has completed enrollment in the REPRISE I clinical trial, which is designed to evaluate the acute safety of the Lotus Aortic Valve System, the first transcatheter aortic valve replacement (TAVR) device of its kind for patients with severe aortic valve stenosis that is both fully repositionable and retrievable prior to release.

23 Apr 2012

FDA clears Smiths Medical's ViaValve Safety I.V. Catheter

Smiths Medical, a leading global medical device manufacturer, today announced that its ViaValve Safety I.V. Catheter has been cleared by the U.S. Food and Drug Administration (FDA) and can be marketed in the United States.

23 Apr 2012

Enrollment complete for In-tunnel SeptRx European PFO Trial in Europe

SeptRx, an emerging medical device company that has developed the SeptRx Intrapocket PFO Occluder (IPO), reported today that it has completed enrollment for its "InterSEPT" (In-tunnel SeptRx European PFO Trial) clinical trial in Europe, and has entered into a partnership with CoRRect Medical GmbH for commercial distribution in Germany and Switzerland of the SeptRx IPO.

23 Apr 2012

ActiViews CT-Guide Needle Guidance System for liver interventions receives FDA 510(k) clearance

ActiViews, Inc, a company pioneering the development of simple, accurate, and cost-effective surgical navigation solutions, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its flagship product, CT-Guide Needle Guidance System, for liver interventions.

23 Apr 2012

Champ Medics to market ETView's VivaSight airway management platform in Taiwan

ETView Medical, Ltd. announced today that it has entered into a distribution agreement with Champ Medics Co., Ltd..

23 Apr 2012

OncoSec reports positive interim data from ElectroChemotherapy Phase IV head and neck cancer study

OncoSec Medical Inc., which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, today announced positive interim analysis of data from 81 subjects in a Phase IV study of primary and locally recurrent squamous cell carcinoma of the head and neck (HNSCC) treated with OMS ElectroChemotherapy in Europe.

23 Apr 2012

RaySearch receives order for its RayStation treatment planning system from HUMC

RaySearch Laboratories has received an order for its RayStation treatment planning system from Hallym University Medical Center in Seoul, South Korea.

23 Apr 2012

HBO2 therapy can reduce neuropathic pain

Chronic pain affects about 76 million people in the U.S. and carries an economic burden of nearly $100 billion annually. The most frequently used medications, narcotic and non-narcotic analgesic drugs (e.g., morphine, ibuprofen, etc.), do not provide complete or sustained relief of chronic pain. Scientists are currently seeking alternative solutions for chronic pain management.

23 Apr 2012